Nemaura Medical Inc.
NMRD · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -84.7% | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -1,916.3% | 31.7% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,458.3% | -1,456.7% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18,358% | -2,755.8% | – | – |
| EPS Diluted | -0.57 | -0.59 | -0.28 | -0.2 |
| % Growth | 3.4% | -110.7% | -40% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |